Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 14.57 Million USD | 52.13% |
| 2022 | 9.57 Million USD | -23.8% |
| 2021 | 12.57 Million USD | 4.18% |
| 2020 | 12.06 Million USD | -9.33% |
| 2019 | 13.3 Million USD | 16.4% |
| 2018 | 11.43 Million GBP | 3.03% |
| 2017 | 11.09 Million GBP | 44.82% |
| 2016 | 7.66 Million GBP | -28.19% |
| 2015 | 10.67 Million GBP | 68.76% |
| 2014 | 6.32 Million GBP | -13.97% |
| 2013 | 7.35 Million GBP | 25.28% |
| 2012 | 5.86 Million GBP | 138.31% |
| 2011 | 2.46 Million GBP | 176.68% |
| 2010 | -3.21 Million GBP | -127.55% |
| 2009 | 11.65 Million GBP | 32.24% |
| 2008 | 8.81 Million GBP | 63.01% |
| 2007 | 5.4 Million GBP | 306.24% |
| 2006 | 1.33 Million GBP | 293.74% |
| 2005 | -687 Thousand GBP | 71.68% |
| 2004 | -2.42 Million GBP | 60.4% |
| 2003 | -6.12 Million GBP | -47.4% |
| 2002 | -4.15 Million GBP | -373.35% |
| 2001 | -878 Thousand GBP | 69.75% |
| 2000 | -2.9 Million GBP | -655.73% |
| 1999 | -384 Thousand GBP | 73.15% |
| 1998 | -1.43 Million GBP | 52.3% |
| 1997 | -2.99 Million GBP | -761.49% |
| 1996 | -348 Thousand GBP | 77.65% |
| 1995 | -1.55 Million GBP | -341.08% |
| 1994 | -353 Thousand GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 14.33 Million USD | 0.0% |
| 2023 Q4 | 14.57 Million USD | 10.21% |
| 2023 Q3 | 13.22 Million GBP | 38.87% |
| 2023 Q1 | 8.9 Million GBP | -7.03% |
| 2023 FY | 14.57 Million USD | 52.13% |
| 2023 Q2 | 9.52 Million USD | 6.92% |
| 2022 Q3 | 8.51 Million GBP | -17.57% |
| 2022 Q2 | 10.32 Million GBP | -5.04% |
| 2022 Q4 | 9.57 Million USD | 12.56% |
| 2022 Q1 | 10.87 Million GBP | -13.51% |
| 2022 FY | 9.57 Million USD | -23.8% |
| 2021 Q3 | 12.18 Million GBP | -1.45% |
| 2021 Q1 | 11.77 Million GBP | -2.45% |
| 2021 FY | 12.57 Million USD | 4.18% |
| 2021 Q4 | 12.57 Million GBP | 3.2% |
| 2021 Q2 | 12.36 Million GBP | 5.0% |
| 2020 Q3 | 11.22 Million GBP | -4.44% |
| 2020 Q1 | 11.16 Million GBP | -16.13% |
| 2020 Q2 | 11.74 Million GBP | 5.18% |
| 2020 Q4 | 12.06 Million GBP | 7.55% |
| 2020 FY | 12.06 Million USD | -9.33% |
| 2019 Q2 | 11.78 Million GBP | -2.28% |
| 2019 FY | 13.3 Million USD | 16.4% |
| 2019 Q1 | 12.06 Million GBP | 34.36% |
| 2019 Q4 | 13.3 Million GBP | 14.39% |
| 2019 Q3 | 11.63 Million GBP | -1.29% |
| 2018 FY | 11.43 Million GBP | 3.03% |
| 2018 Q2 | 8.59 Million GBP | -28.73% |
| 2018 Q1 | 12.06 Million GBP | 47.06% |
| 2018 Q3 | 11.7 Million GBP | 36.07% |
| 2018 Q4 | 8.97 Million GBP | -23.27% |
| 2017 Q4 | 8.2 Million GBP | -23.82% |
| 2017 Q3 | 10.76 Million GBP | 33.56% |
| 2017 Q2 | 8.06 Million GBP | -20.19% |
| 2017 FY | 11.09 Million GBP | 44.82% |
| 2017 Q1 | 10.1 Million GBP | 62.89% |
| 2016 Q1 | 11.82 Million GBP | 63.28% |
| 2016 Q4 | 6.2 Million GBP | -20.02% |
| 2016 Q2 | 8.2 Million GBP | -30.57% |
| 2016 FY | 7.66 Million GBP | -28.19% |
| 2016 Q3 | 7.75 Million GBP | -5.53% |
| 2015 Q4 | 7.24 Million GBP | -31.84% |
| 2015 Q1 | 11.66 Million GBP | 84.39% |
| 2015 FY | 10.67 Million GBP | 68.76% |
| 2015 Q3 | 10.62 Million GBP | 35.35% |
| 2015 Q2 | 7.84 Million GBP | -32.69% |
| 2014 Q3 | 10.25 Million GBP | 123.18% |
| 2014 FY | 6.32 Million GBP | -13.97% |
| 2014 Q2 | 4.59 Million GBP | -40.0% |
| 2014 Q1 | 7.66 Million GBP | 4.23% |
| 2014 Q4 | 6.32 Million GBP | -38.35% |
| 2013 FY | 7.35 Million GBP | 25.28% |
| 2013 Q2 | 7.31 Million GBP | -34.14% |
| 2013 Q1 | 11.11 Million GBP | 89.39% |
| 2013 Q4 | 7.35 Million GBP | -38.23% |
| 2013 Q3 | 11.9 Million GBP | 62.63% |
| 2012 Q4 | 5.86 Million GBP | 0.0% |
| 2012 FY | 5.86 Million GBP | 138.31% |
| 2012 Q2 | 4.21 Million GBP | 0.0% |
| 2011 FY | 2.46 Million GBP | 176.68% |
| 2011 Q4 | 2.46 Million GBP | 0.0% |
| 2011 Q2 | -71 Thousand GBP | 0.0% |
| 2010 Q4 | -3.21 Million GBP | 0.0% |
| 2010 Q2 | 2.29 Million GBP | 0.0% |
| 2010 FY | -3.21 Million GBP | -127.55% |
| 2009 Q2 | 10.67 Million GBP | 0.0% |
| 2009 FY | 11.65 Million GBP | 32.24% |
| 2009 Q4 | 11.65 Million GBP | 0.0% |
| 2008 FY | 8.81 Million GBP | 63.01% |
| 2008 Q4 | 8.81 Million GBP | 0.0% |
| 2008 Q2 | 6.47 Million GBP | 0.0% |
| 2007 Q2 | 3.14 Million GBP | 0.0% |
| 2007 FY | 5.4 Million GBP | 306.24% |
| 2007 Q4 | 5.4 Million GBP | 0.0% |
| 2006 Q4 | 1.33 Million GBP | 0.0% |
| 2006 Q2 | -875 Thousand GBP | 0.0% |
| 2006 FY | 1.33 Million GBP | 293.74% |
| 2005 Q2 | -1.64 Million GBP | 0.0% |
| 2005 Q4 | -687 Thousand GBP | 0.0% |
| 2005 FY | -687 Thousand GBP | 71.68% |
| 2004 Q2 | -1 Million GBP | 0.0% |
| 2004 Q4 | -2.42 Million GBP | 0.0% |
| 2004 FY | -2.42 Million GBP | 60.4% |
| 2003 FY | -6.12 Million GBP | -47.4% |
| 2002 FY | -4.15 Million GBP | -373.35% |
| 2001 FY | -878 Thousand GBP | 69.75% |
| 2000 FY | -2.9 Million GBP | -655.73% |
| 1999 FY | -384 Thousand GBP | 73.15% |
| 1998 FY | -1.43 Million GBP | 52.3% |
| 1997 FY | -2.99 Million GBP | -761.49% |
| 1996 FY | -348 Thousand GBP | 77.65% |
| 1995 FY | -1.55 Million GBP | -341.08% |
| 1994 FY | -353 Thousand GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -560.621% |
| Arrayit Corporation | 1.05 Million USD | -1280.597% |
| Atlantic International Corp. | 236.49 Thousand USD | -6062.178% |
| Biocept, Inc. | -788 Thousand USD | 1949.404% |
| Bioqual, Inc. | -12 Million USD | 221.372% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -63989.467% |
| DermTech, Inc. | 17.65 Million USD | 17.446% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 102.546% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 297.553% |
| iMD Companies, Inc. | 1.11 Million USD | -1205.952% |
| IDenta Corp. | 524.85 Thousand USD | -2676.65% |
| Interpace Biosciences, Inc. | 7.69 Million USD | -89.411% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 54171.327% |
| InVitro International | -313.14 Thousand USD | 4753.896% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -830.658% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 2044041.655% |
| Medical Imaging Corp. | 3.79 Million USD | -284.425% |
| NovelStem International Corp. | 3.52 Million USD | -313.834% |
| Optigenex Inc. | 8.93 Million USD | -63.122% |
| PharmChem, Inc. | -1.49 Million USD | 1075.186% |
| Response Genetics, Inc | -13.08 Million USD | 211.366% |
| Rennova Health, Inc. | 14.82 Million USD | 1.73% |
| RushNet, Inc. | 4.8 Million USD | -203.557% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -10648.146% |
| Stella Diagnostics Inc. | 6.19 Million USD | -135.317% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -716.707% |
| Todos Medical Ltd. | 38.31 Million USD | 61.964% |